Man Group’s Inozyme Pharma INZY Stock Holding History

Man Group’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-670,155	Closed	-$2.68M	–	2335
2025 Q2	$2.68M	Buy	+670,155	New	+$1.66M	0.01%	1298
2023 Q1	–	Hold	0	–	–	–	1902

Man Group's INZY Position: Q3 2025 in Review

Man Group sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 670,155 shares — an estimated $2.68M sold.

Man Group first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $2.68M in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Man Group reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Man Group sold 670,155 Inozyme Pharma shares in Q3 2025, an estimated $2.68M.
Man Group first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
Man Group's Inozyme Pharma position peaked at $2.68M in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Man Group's 13F filing for Q3 2025, filed 14 Nov 2025.